JG
BBNX

Jain Global’s Beta Bionics BBNX Stock Holding History

Jain Global’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7M Buy
172,584
+115,968
+205% +$1.38M 0.01% 702
2026
Q1 		$567K Buy
+56,616
New +$837K ﹤0.01% 913
2025
Q2 		– Sell
-148,512
Closed -$1.82M – 1687
2025
Q1 		$1.82M Buy
+148,512
New +$2.77M 0.02% 371

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Jain Global's BBNX Position: Q2 2026 in Review

Jain Global increased its Beta Bionics (BBNX) stake by 205% in Q2 2026, buying an estimated $1.38M and bringing the position to 172,584 shares worth $2.7M. The position accounts for 0.01% of the portfolio, ranked #702.

Jain Global first reported a position in BBNX in Q1 2025 and has held it in 3 quarters since. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Jain Global held 172,584 shares of Beta Bionics worth $2.7M as of Q2 2026.
  • Jain Global bought 115,968 Beta Bionics shares in Q2 2026, an estimated $1.38M.
  • Beta Bionics made up 0.01% of Jain Global's portfolio in Q2 2026, its #702 holding.
  • Jain Global first reported a position in Beta Bionics in Q1 2025 and has held it in 3 quarters since.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.